Analyst price target range
Parabilis Medicines Price Target: $41.75 Average
Direct answer
Parabilis Medicines's average price target is $41.75.
The verified analyst range runs from $40.00 to $45.00.
The low target implies +0.1%, the high target implies +12.6%, and the range spans 12.5% of the current price.
Forecast evidence checked September 18, 2026.
Get free Parabilis Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $39.97
- Average price target
- $41.75
- High price target
- $45.00
- Low price target
- $40.00
- Low target gap
- +0.1%
- Target upside
- +4.5%
- High target gap
- +12.6%
- Target range width
- 12.5%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- September 18, 2026
- Valid through
- September 25, 2026
Explore related company data
Read the frequently asked questions.
What is Parabilis Medicines's average price target?
Parabilis Medicines's verified average price target is $41.75. The target range is $40.00 to $45.00.
How far are Parabilis Medicines's low and high targets from the recorded price?
The low target implies +0.1%, while the high target implies +12.6%.
How many analysts are included in Parabilis Medicines's consensus?
The verified consensus includes 4 analysts.
How is Parabilis Medicines's target upside or downside calculated?
The average target of $41.75 is divided by the recorded price of $39.97, then one is subtracted to produce +4.5%. This does not guarantee a future return.
When was Parabilis Medicines's analyst forecast verified?
The data was verified on 2026-09-18. The dataset is valid through 2026-09-25.